\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ recent\\ physical\\ exam\\ on\\ record\ \(0\)\
\-\ 24jun2004\\:\\ biopsy\\ of\\ esophagus\\ \\â\\€\\“\\ no\\ metaplasia\\ present\ \(0\)\
\-\ 25june2005\\:\\ all\\ values\\ of\\ basic\\ metabolic\\ panel\\ are\\ within\\ normal\\ limits\ \(0\)\
\-\ patient\\ has\\ had\\ stable\\ postoperative\\ films\\ since\\ 2001\\.\\ continue\\ with\\ annual\\ biopsies\\ and\\ ct\\ and\\ plain\\ films\\ twice\\ a\\ year\\ for\\ at\\ least\\ five\\ years\\.\ \(0\)\
\-\ chest\\ pa\\:\\ descending\\ aorta\\ shadow\\ obscured\\ by\\ retrocardiac\\ opacity\\.\\ \ \(0\)\
\-\ chest\\ lat\\:\\ abnormal\\ soft\\ tissue\\ density\\ in\\ a\\ retrocardiac\\ position\\ obscuring\\ the\\ posterior\\ border\\ of\\ left\\ ventricle\\.\\ \\ \ \(0\)\
\-\ ct\\:\\ dilated\\ esophagus\\ with\\ air\\ contrast\\ level\\ extending\\ from\\ the\\ thoracic\\ inlet\\ to\\ the\\ diaphragm\\.\\ lower\\ images\\ show\\ surgical\\ clips\\.\ \(0\)\
\-\ gastric\\ pull\\ through\ \(2\)\
\-\ \\(lower\\ middle\\ mediastinal\\ mass\\)\ \(0\)\
\-\ esophageal\\ processes\\:\\ achalasia\\,\\ esophageal\\ mass\\ \\(leiomyoma\\)\\,\\ hiatal\\ hernia\\,\\ or\\ gastric\\ pull\\ through\ \(0\)\
\-\ tracheal\\ or\\ esophageal\\ duplication\\ cysts\ \(0\)\
\-\ aortic\\ ectasia\\ or\\ aneurysm\ \(0\)\
\-\ 46\\-year\\-old\\ caucasian\\ male\\ with\\ a\\ history\\ of\\ squamous\\ cell\\ carcinoma\\ of\\ the\\ middle\\ third\\ of\\ the\\ esophagus\\ in\\ 2001\\.\\ pt\\ is\\ s\\/p\\ transhiatal\\ esophagectomy\\ and\\ chemoradiation\\ and\\ neoadjuvant\\ chemotherapy\\.\\ here\\ for\\ follow\\-up\\ and\\ screening\\ for\\ recurrence\\.\ \(0\)\
\-\ malignant\\ epithelial\\ tumors\\ of\\ the\\ esophagus\\ are\\ almost\\ always\\ primary\\ carcinomas\\.\\ worldwide\\,\\ squamous\\ cell\\ carcinoma\\ \\(scca\\)\\ is\\ the\\ most\\ common\\ type\\ and\\ ranks\\ fifth\\ in\\ mortality\\ rate\\ among\\ tumor\\ sites\\.\\ genetic\\ predisposition\\,\\ dietary\\ habits\\,\\ environmental\\ exposures\\,\\ and\\ alcohol\\ and\\ tobacco\\ use\\ have\\ all\\ been\\ implicated\\ as\\ causative\\ factors\\ for\\ the\\ disease\\.\\ 1\ \(0\)\
\-\ clinically\\,\\ patients\\ with\\ esophageal\\ cancer\\ present\\ with\\ dysphagia\\ \\(90\\%\\)\\ and\\/or\\ odynophagia\\ \\(50\\%\\)\\.\\ by\\ the\\ time\\ they\\ seek\\ treatment\\ upwards\\ of\\ 75\\%\\ have\\ experienced\\ anorexia\\ and\\ weight\\ loss\\ and\\ report\\ considerably\\ altered\\ diets\\ due\\ to\\ luminal\\ compromise\\.\\ generally\\ there\\ are\\ no\\ specific\\ physical\\ findings\\ with\\ scca\\.\\ patients\\ with\\ symptoms\\ of\\ esophageal\\ cancer\\ are\\ often\\ worked\\ up\\ in\\ the\\ following\\ manner\\.\\ pa\\ and\\ lateral\\ chest\\ radiographs\\ are\\ obtained\\ in\\ those\\ with\\ chronic\\ cough\\ or\\ abnormal\\ findings\\ on\\ chest\\ auscultation\\ to\\ demonstrate\\ metastases\\ or\\ infiltrates\\ suggestive\\ of\\ aspiration\\ or\\ esophagorespiratory\\ fistula\\.\\ \\ findings\\ may\\ include\\ lateral\\ deviation\\ of\\ the\\ mediastinal\\ contents\\,\\ widening\\ of\\ the\\ mediastinum\\,\\ and\\ esophageal\\ air\\-fluid\\ levels\\.\\ contrast\\ esophagography\\ using\\ barium\\ is\\ usually\\ indicated\\ to\\ rule\\ out\\ other\\ disorders\\ with\\ similar\\ presentations\\ such\\ as\\ achalasia\\.\\ barium\\ swallows\\ in\\ patients\\ with\\ scaa\\ can\\ demonstrate\\ high\\-grade\\ stenosis\\,\\ complete\\ obstruction\\,\\ and\\ fistulas\\.\\ flexible\\ endoscopy\\ is\\ also\\ generally\\ indicated\\ since\\ it\\ allows\\ direct\\ visualization\\ of\\ the\\ esophagus\\ as\\ well\\ as\\ the\\ opportunity\\ to\\ obtain\\ tissue\\ samples\\.\\ obtaining\\ at\\ least\\ six\\ biopsy\\ samples\\ yields\\ a\\ diagnosis\\ with\\ an\\ accuracy\\ approaching\\ 100\\%\\.\\ endoscopy\\ aids\\ in\\ accurate\\ characterization\\ of\\ the\\ tumor\\â\\€\\™s\\ configuration\\,\\ length\\,\\ and\\ localization\\.\\ it\\ also\\ aids\\ in\\ initial\\ relief\\ of\\ dysphagia\\ because\\ dilation\\ can\\ be\\ performed\\ at\\ the\\ same\\ time\\.\\ 1\ \(0\)\
\-\ esophageal\\ cancer\\ is\\ considered\\ a\\ treatable\\ disease\\,\\ but\\ one\\ that\\ is\\ rarely\\ curable\\.\\ the\\ overall\\ five\\-year\\ survival\\ rate\\ in\\ patients\\ that\\ are\\ amenable\\ to\\ surgery\\ ranges\\ from\\ 5\\-20\\%\\.\\ radiation\\ or\\ chemoradiotherapy\\ alone\\ are\\ considered\\ suboptimal\\ primary\\ treatment\\ modalities\\ because\\ of\\ locally\\ persistent\\ or\\ recurrent\\ disease\\.\\ current\\ studies\\ suggest\\ combined\\ modality\\ therapy\\ with\\ preoperative\\ chemoradiotherapy\\ followed\\ by\\ surgery\\ is\\ acceptable\\ management\\ for\\ patients\\ with\\ stage\\ ii\\ and\\ iii\\ cancer\\.\\ optimal\\ treatment\\ for\\ patients\\ with\\ earlier\\ stage\\ disease\\ is\\ less\\ clear\\ and\\ surgery\\ alone\\ is\\ considered\\ reasonable\\.\\ 2\\ \ \(0\)\
\-\ 1\\.\\ feldman\\:\\ sleisenger\\ and\\ fordtran\\â\\€\\™s\\ gastrointestinal\\ and\\ liver\\ disease\\,\\ 7th\\ ed\\.\\,\\ chapter\\ 35\\ \\â\\€\\“\\ esophageal\\ tumors\\,\\ copyright\\ 2002\\ elsevier\ \(0\)\
\-\ 2\\.\\ radiation\\ therapy\\,\\ chemoradiotherapy\\,\\ and\\ neoadjuvant\\ approaches\\ for\\ localized\\ esophageal\\ cancer\\.\\ by\\:\\ forastiere\\,\\ a\\,\\ et\\ al\\.\\ uptodate\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ esophageal\\:\\ 0\\.3160758878912017\ \(0\)\
\-\ chemoradiotherapy\\:\\ 0\\.1822122860520292\ \(0\)\
\-\ and\\:\\ 0\\.16986662260363367\ \(0\)\
\-\ esophagus\\:\\ 0\\.1692442591686052\ \(0\)\
\-\ the\\:\\ 0\\.13942449212470426\ \(0\)\
\-\ patients\\:\\ 0\\.13873446931774336\ \(0\)\
\-\ cancer\\:\\ 0\\.1368859000581188\ \(0\)\
\-\ of\\:\\ 0\\.1286972783811451\ \(0\)\
\-\ or\\:\\ 0\\.12868949200085525\ \(0\)\
\-\ scca\\:\\ 0\\.12147485736801947\ \(0\)\
\-\ with\\:\\ 0\\.11267740310252211\ \(0\)\
\-\ samples\\:\\ 0\\.11148598153474736\ \(0\)\
\-\ are\\:\\ 0\\.10917574091556284\ \(0\)\
\-\ neoadjuvant\\:\\ 0\\.10827028176767566\ \(0\)\
\-\ is\\:\\ 0\\.10130582233923774\ \(0\)\
\-\ pull\\:\\ 0\\.0997997459610994\ \(0\)\
\-\ retrocardiac\\:\\ 0\\.09902058855403537\ \(0\)\
\-\ considered\\:\\ 0\\.09608530909165162\ \(0\)\
\-\ achalasia\\:\\ 0\\.09243828814757957\ \(0\)\
\-\ in\\:\\ 0\\.09202474197731514\ \(0\)\
\-\ aids\\:\\ 0\\.08941602620607461\ \(0\)\
\-\ for\\:\\ 0\\.08720499405057601\ \(0\)\
\-\ chest\\:\\ 0\\.08678395712919984\ \(0\)\
\-\ disease\\:\\ 0\\.08626687425182047\ \(0\)\
\-\ endoscopy\\:\\ 0\\.08507683033405973\ \(0\)\
\-\ alone\\:\\ 0\\.08085919731752686\ \(0\)\
\-\ least\\:\\ 0\\.07597963485700614\ \(0\)\
\-\ five\\:\\ 0\\.07424824699780022\ \(0\)\
\-\ dysphagia\\:\\ 0\\.07424824699780022\ \(0\)\
\-\ squamous\\:\\ 0\\.0739788765077312\ \(0\)\
\-\ barium\\:\\ 0\\.07319971910066717\ \(0\)\
\-\ by\\:\\ 0\\.06981804372139216\ \(0\)\
\-\ generally\\:\\ 0\\.06963434425290076\ \(0\)\
\-\ gastric\\:\\ 0\\.06924483671396363\ \(0\)\
\-\ indicated\\:\\ 0\\.06761166817829255\ \(0\)\
\-\ mediastinal\\:\\ 0\\.0663792165498011\ \(0\)\
\-\ surgery\\:\\ 0\\.06629534861969176\ \(0\)\
\-\ as\\:\\ 0\\.066049353135332\ \(0\)\
\-\ 24jun2004\\:\\ 0\\.06573186660064578\ \(0\)\
\-\ 25june2005\\:\\ 0\\.06573186660064578\ \(0\)\
\-\ ranks\\:\\ 0\\.06573186660064578\ \(0\)\
\-\ esophagorespiratory\\:\\ 0\\.06573186660064578\ \(0\)\
\-\ scaa\\:\\ 0\\.06573186660064578\ \(0\)\
\-\ curable\\:\\ 0\\.06573186660064578\ \(0\)\
\-\ forastiere\\:\\ 0\\.06573186660064578\ \(0\)\
\-\ stage\\:\\ 0\\.06546393110783184\ \(0\)\
\-\ films\\:\\ 0\\.06509907866751549\ \(0\)\
\-\ pa\\:\\ 0\\.06308498306450863\ \(0\)\
\-\ transhiatal\\:\\ 0\\.06281030770723381\ \(0\)\
\-\ esophagography\\:\\ 0\\.06281030770723381\ \(0\)\
\-\ opportunity\\:\\ 0\\.06281030770723381\ \(0\)\
\-\ feldman\\:\\ 0\\.06281030770723381\ \(0\)\
\-\ sleisenger\\:\\ 0\\.06281030770723381\ \(0\)\
\-\ fordtran\\:\\ 0\\.06281030770723381\ \(0\)\
\-\ rate\\:\\ 0\\.06229264093408325\ \(0\)\
\-\ to\\:\\ 0\\.061653285327570716\ \(0\)\
\-\ findings\\:\\ 0\\.06085721663912644\ \(0\)\
\-\ chemoradiation\\:\\ 0\\.060737428684009734\ \(0\)\
\-\ upwards\\:\\ 0\\.060737428684009734\ \(0\)\
\-\ diets\\:\\ 0\\.060737428684009734\ \(0\)\
\-\ tumors\\:\\ 0\\.060457565044756356\ \(0\)\
\-\ since\\:\\ 0\\.05954710010847806\ \(0\)\
\-\ environmental\\:\\ 0\\.059129578800473884\ \(0\)\
\-\ swallows\\:\\ 0\\.059129578800473884\ \(0\)\
\-\ yields\\:\\ 0\\.059129578800473884\ \(0\)\
\-\ middle\\:\\ 0\\.058783429969566335\ \(0\)\
\-\ treatment\\:\\ 0\\.058737923974722904\ \(0\)\
\-\ copyright\\:\\ 0\\.057815869790597746\ \(0\)\
\-\ biopsy\\:\\ 0\\.05762279234502044\ \(0\)\
\-\ because\\:\\ 0\\.05745224714004026\ \(0\)\
\-\ exposures\\:\\ 0\\.05670514464910249\ \(0\)\
\-\ treatable\\:\\ 0\\.05670514464910249\ \(0\)\
\-\ considerably\\:\\ 0\\.05574299076737368\ \(0\)\
\-\ flexible\\:\\ 0\\.05574299076737368\ \(0\)\
\-\ metaplasia\\:\\ 0\\.05489431089718576\ \(0\)\
\-\ esophagectomy\\:\\ 0\\.05489431089718576\ \(0\)\
\-\ worldwide\\:\\ 0\\.05489431089718576\ \(0\)\
\-\ approaching\\:\\ 0\\.05489431089718576\ \(0\)\
\-\ amenable\\:\\ 0\\.05489431089718576\ \(0\)\
\-\ radiation\\:\\ 0\\.05447587982849973\ \(0\)\
\-\ record\\:\\ 0\\.05413514088383783\ \(0\)\
\-\ air\\:\\ 0\\.05376948653274932\ \(0\)\
\-\ predisposition\\:\\ 0\\.053448388071150085\ \(0\)\
\-\ implicated\\:\\ 0\\.053448388071150085\ \(0\)\
\-\ approaches\\:\\ 0\\.053448388071150085\ \(0\)\
\-\ habits\\:\\ 0\\.05282143187396169\ \(0\)\
\-\ suboptimal\\:\\ 0\\.05282143187396169\ \(0\)\
\-\ presentations\\:\\ 0\\.052244688080771935\ \(0\)\
\-\ causative\\:\\ 0\\.05171070673246644\ \(0\)\
\-\ characterization\\:\\ 0\\.05171070673246644\ \(0\)\
\-\ obscuring\\:\\ 0\\.05121358199042584\ \(0\)\
\-\ optimal\\:\\ 0\\.05121358199042584\ \(0\)\
\-\ chapter\\:\\ 0\\.05121358199042584\ \(0\)\
\-\ acceptable\\:\\ 0\\.05074855285073762\ \(0\)\
\-\ primary\\:\\ 0\\.05054722292970501\ \(0\)\
\-\ odynophagia\\:\\ 0\\.05031172512010021\ \(0\)\
\-\ elsevier\\:\\ 0\\.05031172512010021\ \(0\)\
\-\ inlet\\:\\ 0\\.04951029427701768\ \(0\)\
\-\ abnormal\\:\\ 0\\.049387679070225766\ \(0\)\
\-\ carcinoma\\:\\ 0\\.049171331195932866\ \(0\)\
\-\ obscured\\:\\ 0\\.04914070296720177\ \(0\)\
\-\ anorexia\\:\\ 0\\.04914070296720177\ \(0\)\
\-\ worked\\:\\ 0\\.04914070296720177\ \(0\)\
\-\ fistulas\\:\\ 0\\.04914070296720177\ \(0\)\
\-\ locally\\:\\ 0\\.04914070296720177\ \(0\)\
\-\ all\\:\\ 0\\.04893469366817131\ \(0\)\
\-\ through\\:\\ 0\\.04893469366817131\ \(0\)\
\-\ seek\\:\\ 0\\.04878914783905444\ \(0\)\
\-\ manner\\:\\ 0\\.04878914783905444\ \(0\)\
\-\ 7th\\:\\ 0\\.04878914783905444\ \(0\)\
\-\ time\\:\\ 0\\.04872499212691243\ \(0\)\
\-\ obtaining\\:\\ 0\\.04845395015451403\ \(0\)\
\-\ dietary\\:\\ 0\\.04813365516569834\ \(0\)\
\-\ accuracy\\:\\ 0\\.04813365516569834\ \(0\)\
\-\ uptodate\\:\\ 0\\.047826993957325634\ \(0\)\
\-\ luminal\\:\\ 0\\.04753285308366592\ \(0\)\
\-\ ranges\\:\\ 0\\.04753285308366592\ \(0\)\
\-\ reasonable\\:\\ 0\\.04753285308366592\ \(0\)\
\-\ therapy\\:\\ 0\\.047232119199448815\ \(0\)\
\-\ cell\\:\\ 0\\.04702506245311404\ \(0\)\
\-\ accurate\\:\\ 0\\.046978314087137714\ \(0\)\
\-\ localization\\:\\ 0\\.046978314087137714\ \(0\)\
\-\ biopsies\\:\\ 0\\.04671626881583038\ \(0\)\
\-\ at\\:\\ 0\\.046574818704435944\ \(0\)\
\-\ basic\\:\\ 0\\.046219144073789784\ \(0\)\
\-\ twice\\:\\ 0\\.046219144073789784\ \(0\)\
\-\ clips\\:\\ 0\\.046219144073789784\ \(0\)\
\-\ ectasia\\:\\ 0\\.04598287861822719\ \(0\)\
\-\ carcinomas\\:\\ 0\\.04598287861822719\ \(0\)\
\-\ obtain\\:\\ 0\\.04598287861822719\ \(0\)\
\-\ infiltrates\\:\\ 0\\.04531728720346415\ \(0\)\
\-\ allows\\:\\ 0\\.044905435063913646\ \(0\)\
\-\ preoperative\\:\\ 0\\.044708013103037306\ \(0\)\
\-\ physical\\:\\ 0\\.04457345237461795\ \(0\)\
\-\ tracheal\\:\\ 0\\.04451585636038163\ \(0\)\
\-\ compromise\\:\\ 0\\.04432869127072389\ \(0\)\
\-\ epithelial\\:\\ 0\\.044146265050565715\ \(0\)\
\-\ modalities\\:\\ 0\\.043968343645067784\ \(0\)\
\-\ tobacco\\:\\ 0\\.043625162080691844\ \(0\)\
\-\ among\\:\\ 0\\.04345951223787797\ \(0\)\
\-\ panel\\:\\ 0\\.043139217249062285\ \(0\)\
\-\ lat\\:\\ 0\\.043139217249062285\ \(0\)\
\-\ can\\:\\ 0\\.043138593546640035\ \(0\)\
\-\ tissue\\:\\ 0\\.043122903940704053\ \(0\)\
\-\ tumor\\:\\ 0\\.04299799826922983\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04273611470993858\ \(0\)\
\-\ postoperative\\:\\ 0\\.04268398478092313\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.04268398478092313\ \(0\)\
\-\ present\\:\\ 0\\.04218206895747614\ \(0\)\
\-\ it\\:\\ 0\\.04207960401447132\ \(0\)\
\-\ lower\\:\\ 0\\.042006858268735785\ \(0\)\
\-\ shadow\\:\\ 0\\.04198387617050166\ \(0\)\
\-\ hiatal\\:\\ 0\\.04172183089919432\ \(0\)\
\-\ altered\\:\\ 0\\.04172183089919432\ \(0\)\
\-\ duplication\\:\\ 0\\.04159429746696964\ \(0\)\
\-\ configuration\\:\\ 0\\.041468982120283285\ \(0\)\
\-\ deviation\\:\\ 0\\.04134580902151352\ \(0\)\
\-\ contents\\:\\ 0\\.0411056050849486\ \(0\)\
\-\ have\\:\\ 0\\.041065919730912184\ \(0\)\
\-\ fifth\\:\\ 0\\.0408731510290064\ \(0\)\
\-\ lateral\\:\\ 0\\.04079654924084316\ \(0\)\
\-\ combined\\:\\ 0\\.04075967701746551\ \(0\)\
\-\ up\\:\\ 0\\.04066372893078028\ \(0\)\
\-\ modality\\:\\ 0\\.04064796236396397\ \(0\)\
\-\ genetic\\:\\ 0\\.040537953344465985\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.040537953344465985\ \(0\)\
\-\ processes\\:\\ 0\\.04042959865876343\ \(0\)\
\-\ mortality\\:\\ 0\\.04042959865876343\ \(0\)\
\-\ continue\\:\\ 0\\.0403228492868281\ \(0\)\
\-\ sites\\:\\ 0\\.04011398101565847\ \(0\)\
\-\ survival\\:\\ 0\\.04011398101565847\ \(0\)\
\-\ no\\:\\ 0\\.04009820876498741\ \(0\)\
\-\ contrast\\:\\ 0\\.03994174388248978\ \(0\)\
\-\ diaphragm\\:\\ 0\\.039811610043086434\ \(0\)\
\-\ visualization\\:\\ 0\\.039334253354087835\ \(0\)\
\-\ 2002\\:\\ 0\\.039334253354087835\ \(0\)\
\-\ here\\:\\ 0\\.03915182713392966\ \(0\)\
\-\ experienced\\:\\ 0\\.03906231727708967\ \(0\)\
\-\ always\\:\\ 0\\.03880027200578233\ \(0\)\
\-\ also\\:\\ 0\\.0386668884505239\ \(0\)\
\-\ relief\\:\\ 0\\.0385474232268713\ \(0\)\
\-\ auscultation\\:\\ 0\\.03846507432124192\ \(0\)\
\-\ year\\:\\ 0\\.03800095595818486\ \(0\)\
\-\ annual\\:\\ 0\\.03798981742850307\ \(0\)\
\-\ alcohol\\:\\ 0\\.03798981742850307\ \(0\)\
\-\ values\\:\\ 0\\.037913568560209714\ \(0\)\
\-\ widening\\:\\ 0\\.037913568560209714\ \(0\)\
\-\ overall\\:\\ 0\\.03776344957176922\ \(0\)\
\-\ earlier\\:\\ 0\\.0375439772503938\ \(0\)\
\-\ length\\:\\ 0\\.037472280630844707\ \(0\)\
\-\ metabolic\\:\\ 0\\.03726137433086377\ \(0\)\
\-\ descending\\:\\ 0\\.03712412349890011\ \(0\)\
\-\ fistula\\:\\ 0\\.03712412349890011\ \(0\)\
\-\ almost\\:\\ 0\\.03692302809883416\ \(0\)\
\-\ six\\:\\ 0\\.03692302809883416\ \(0\)\
\-\ localized\\:\\ 0\\.03692302809883416\ \(0\)\
\-\ mediastinum\\:\\ 0\\.036792016292989255\ \(0\)\
\-\ rarely\\:\\ 0\\.03666334410915188\ \(0\)\
\-\ caucasian\\:\\ 0\\.03653692944889037\ \(0\)\
\-\ border\\:\\ 0\\.03635137110487746\ \(0\)\
\-\ disorders\\:\\ 0\\.03629056525192085\ \(0\)\
\-\ direct\\:\\ 0\\.036230268240517664\ \(0\)\
\-\ dilation\\:\\ 0\\.036170471625018324\ \(0\)\
\-\ 75\\:\\ 0\\.03605234683501973\ \(0\)\
\-\ current\\:\\ 0\\.03599400278495508\ \(0\)\
\-\ aspiration\\:\\ 0\\.03593612736685795\ \(0\)\
\-\ opacity\\:\\ 0\\.03576523910082946\ \(0\)\
\-\ that\\:\\ 0\\.035673898614359836\ \(0\)\
\-\ iii\\:\\ 0\\.03548913440883832\ \(0\)\
\-\ those\\:\\ 0\\.0351711952973738\ \(0\)\
\-\ factors\\:\\ 0\\.03476798797087508\ \(0\)\
\-\ report\\:\\ 0\\.034622418356981814\ \(0\)\
\-\ clinically\\:\\ 0\\.0341573892172936\ \(0\)\
\-\ hernia\\:\\ 0\\.034023537984739255\ \(0\)\
\-\ recurrence\\:\\ 0\\.03393566554429408\ \(0\)\
\-\ using\\:\\ 0\\.033805834089146274\ \(0\)\
\-\ 100\\:\\ 0\\.033720561486656184\ \(0\)\
\-\ suggestive\\:\\ 0\\.03347063640460586\ \(0\)\
\-\ aorta\\:\\ 0\\.033389218014999514\ \(0\)\
\-\ screening\\:\\ 0\\.033389218014999514\ \(0\)\
\-\ suggest\\:\\ 0\\.033389218014999514\ \(0\)\
\-\ metastases\\:\\ 0\\.03322909029595652\ \(0\)\
\-\ recurrent\\:\\ 0\\.032957154218958354\ \(0\)\
\-\ 35\\:\\ 0\\.032957154218958354\ \(0\)\
\-\ 90\\:\\ 0\\.032843680207417465\ \(0\)\
\-\ position\\:\\ 0\\.032769011655133164\ \(0\)\
\-\ al\\:\\ 0\\.032658439907624084\ \(0\)\
\-\ from\\:\\ 0\\.03264835133046123\ \(0\)\
\-\ rule\\:\\ 0\\.03262195653441794\ \(0\)\
\-\ levels\\:\\ 0\\.03258565695732221\ \(0\)\
\-\ stable\\:\\ 0\\.03251360184871538\ \(0\)\
\-\ same\\:\\ 0\\.03251360184871538\ \(0\)\
\-\ limits\\:\\ 0\\.03247784271420865\ \(0\)\
\-\ ii\\:\\ 0\\.032406852476780046\ \(0\)\
\-\ et\\:\\ 0\\.03219798420561043\ \(0\)\
\-\ aortic\\:\\ 0\\.03176519427323746\ \(0\)\
\-\ persistent\\:\\ 0\\.03166890619251582\ \(0\)\
\-\ use\\:\\ 0\\.031449115052936585\ \(0\)\
\-\ mass\\:\\ 0\\.03140012557935272\ \(0\)\
\-\ similar\\:\\ 0\\.03132646612037767\ \(0\)\
\-\ ct\\:\\ 0\\.03129622533383016\ \(0\)\
\-\ aneurysm\\:\\ 0\\.03129612733528479\ \(0\)\
\-\ third\\:\\ 0\\.03129612733528479\ \(0\)\
\-\ stenosis\\:\\ 0\\.031265915757211514\ \(0\)\
\-\ cysts\\:\\ 0\\.031146320467041626\ \(0\)\
\-\ specific\\:\\ 0\\.031146320467041626\ \(0\)\
\-\ thoracic\\:\\ 0\\.030714727354007744\ \(0\)\
\-\ cough\\:\\ 0\\.030686853234857946\ \(0\)\
\-\ management\\:\\ 0\\.030360512897240313\ \(0\)\
\-\ ventricle\\:\\ 0\\.030254936637534154\ \(0\)\
\-\ studies\\:\\ 0\\.030150884998131094\ \(0\)\
\-\ clear\\:\\ 0\\.029798100165942153\ \(0\)\
\-\ pt\\:\\ 0\\.029580103514602493\ \(0\)\
\-\ dilated\\:\\ 0\\.029438352369698613\ \(0\)\
\-\ they\\:\\ 0\\.029368509003970016\ \(0\)\
\-\ malignant\\:\\ 0\\.029299336144901343\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.029185503590787584\ \(0\)\
\-\ obtained\\:\\ 0\\.029073441443817554\ \(0\)\
\-\ complete\\:\\ 0\\.02881139617251022\ \(0\)\
\-\ obstruction\\:\\ 0\\.02878998322713958\ \(0\)\
\-\ 50\\:\\ 0\\.028704962172095422\ \(0\)\
\-\ weight\\:\\ 0\\.028662824912743773\ \(0\)\
\-\ liver\\:\\ 0\\.02835441332155805\ \(0\)\
\-\ less\\:\\ 0\\.027962716302322298\ \(0\)\
\-\ extending\\:\\ 0\\.027868030960656456\ \(0\)\
\-\ recent\\:\\ 0\\.027830502486162763\ \(0\)\
\-\ followed\\:\\ 0\\.027756026879313923\ \(0\)\
\-\ type\\:\\ 0\\.027573137598790282\ \(0\)\
\-\ initial\\:\\ 0\\.027573137598790282\ \(0\)\
\-\ density\\:\\ 0\\.027255198487325757\ \(0\)\
\-\ plain\\:\\ 0\\.027118273686484277\ \(0\)\
\-\ out\\:\\ 0\\.027017261039456238\ \(0\)\
\-\ often\\:\\ 0\\.026819387255358908\ \(0\)\
\-\ radiographs\\:\\ 0\\.0266585446211905\ \(0\)\
\-\ such\\:\\ 0\\.026439231362295132\ \(0\)\
\-\ show\\:\\ 0\\.02609282114747911\ \(0\)\
\-\ usually\\:\\ 0\\.025875554914036744\ \(0\)\
\-\ years\\:\\ 0\\.025195290576181296\ \(0\)\
\-\ loss\\:\\ 0\\.02504115740891031\ \(0\)\
\-\ level\\:\\ 0\\.024828296293178273\ \(0\)\
\-\ on\\:\\ 0\\.024827328980844415\ \(0\)\
\-\ following\\:\\ 0\\.02465760081255237\ \(0\)\
\-\ include\\:\\ 0\\.024455621118211767\ \(0\)\
\-\ chronic\\:\\ 0\\.024397277068147108\ \(0\)\
\-\ performed\\:\\ 0\\.024316381020837878\ \(0\)\
\-\ been\\:\\ 0\\.023946789711021963\ \(0\)\
\-\ due\\:\\ 0\\.023626494722206272\ \(0\)\
\-\ one\\:\\ 0\\.02353311824288854\ \(0\)\
\-\ common\\:\\ 0\\.023309832886531646\ \(0\)\
\-\ symptoms\\:\\ 0\\.022488966880936538\ \(0\)\
\-\ soft\\:\\ 0\\.02188210335589411\ \(0\)\
\-\ most\\:\\ 0\\.02139099249628904\ \(0\)\
\-\ other\\:\\ 0\\.021345194985240866\ \(0\)\
\-\ diagnosis\\:\\ 0\\.02130725150201268\ \(0\)\
\-\ posterior\\:\\ 0\\.02125446408046523\ \(0\)\
\-\ exam\\:\\ 0\\.020691025687766956\ \(0\)\
\-\ may\\:\\ 0\\.020684080674396168\ \(0\)\
\-\ had\\:\\ 0\\.020478783288315414\ \(0\)\
\-\ but\\:\\ 0\\.020325256990544396\ \(0\)\
\-\ surgical\\:\\ 0\\.019977162164965503\ \(0\)\
\-\ well\\:\\ 0\\.019902039495125663\ \(0\)\
\-\ images\\:\\ 0\\.01901264880578909\ \(0\)\
\-\ within\\:\\ 0\\.018930550111143824\ \(0\)\
\-\ has\\:\\ 0\\.01877443038888797\ \(0\)\
\-\ male\\:\\ 0\\.018300420006110603\ \(0\)\
\-\ normal\\:\\ 0\\.016781880523329292\ \(0\)\
\-\ be\\:\\ 0\\.016673646403704938\ \(0\)\
\-\ there\\:\\ 0\\.016354562429566958\ \(0\)\
\-\ an\\:\\ 0\\.01571746306573525\ \(0\)\
\-\ history\\:\\ 0\\.015703539484949777\ \(0\)\
\-\ left\\:\\ 0\\.014020963687969458\ \(0\)\
\-\ patient\\:\\ 0\\.013368584141072979\ \(0\)\
